The challenges in healthcare and life science research today are too big to be tackled by any one institution alone.
Clover Therapeutics is partnering with biopharmaceutical, non-profit, and academic research institutions to develop joint research programs for diseases of aging.
Modern drug development is increasingly focused on medicines that can target specific types of individuals in a given context - “right treatment, right patient, right time.” The path to do so requires a robust understanding of disease complexity and patient diversity.
Recent advances in human genetics and phenotyping significantly increase the probability of success in tackling these challenges.
Clover Therapeutics plans to improve our understanding of human disease biology by partnering with an engaged community of research participants and leading researchers from all sectors.